Principal Financial Group’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-123,655
Closed -$1.39M 2277
2025
Q2
$1.39M Buy
123,655
+60,901
+97% +$559K ﹤0.01% 1845
2025
Q1
$594K Buy
62,754
+299
+0.5% +$3.02K ﹤0.01% 1912
2024
Q4
$703K Buy
62,455
+5,073
+9% +$89.2K ﹤0.01% 1920
2024
Q3
$1.62M Buy
57,382
+41,788
+268% +$1.08M ﹤0.01% 1799
2024
Q2
$298K Buy
15,594
+480
+3% +$12.3K ﹤0.01% 2059
2024
Q1
$496K Buy
15,114
+2,398
+19% +$76.5K ﹤0.01% 1984
2023
Q4
$420K Buy
12,716
+1,202
+10% +$34K ﹤0.01% 1990
2023
Q3
$314K Sell
11,514
-104,781
-90% -$2.91M ﹤0.01% 2050
2023
Q2
$3.52M Sell
116,295
-11,911
-9% -$385K ﹤0.01% 1643
2023
Q1
$4.16M Buy
128,206
+88,680
+224% +$2.8M ﹤0.01% 1596
2022
Q4
$1.11M Buy
39,526
+6,084
+18% +$174K ﹤0.01% 1845
2022
Q3
$1.2M Sell
33,442
-571,111
-94% -$20.1M ﹤0.01% 1813
2022
Q2
$18.6M Sell
604,553
-22,311
-4% -$650K 0.01% 870
2022
Q1
$20.2M Buy
626,864
+247,386
+65% +$6.48M 0.01% 899
2021
Q4
$10.5M Buy
379,478
+194,279
+105% +$5.57M 0.01% 1367
2021
Q3
$5.74M Buy
185,199
+72,625
+65% +$1.74M ﹤0.01% 1633
2021
Q2
$2.38M Buy
112,574
+93,552
+492% +$1.87M ﹤0.01% 1867
2021
Q1
$384K Buy
19,022
+1,341
+8% +$25.5K ﹤0.01% 2214
2020
Q4
$283K Buy
+17,681
New +$234K ﹤0.01% 2249
2018
Q4
Sell
-7,055
Closed -$200K 2263
2018
Q3
$200K Buy
+7,055
New +$168K ﹤0.01% 2171

Other funds holding EVH

Principal Financial Group's EVH Position: Q3 2025 in Review

Principal Financial Group sold out of Evolent Health (EVH) in Q3 2025, closing a stake of 123,655 shares — an estimated $1.39M sold.

Principal Financial Group first reported a position in EVH in Q3 2018 and held it in 20 quarters. The position peaked at $20.2M in Q1 2022. 240 funds tracked by Wall St. Rank hold EVH as of Q3 2025.

  • Principal Financial Group reported no remaining Evolent Health position as of Q3 2025 after selling out during the quarter.
  • Principal Financial Group sold 123,655 Evolent Health shares in Q3 2025, an estimated $1.39M.
  • Principal Financial Group first reported a position in Evolent Health in Q3 2018 and held it in 20 quarters.
  • Principal Financial Group's Evolent Health position peaked at $20.2M in Q1 2022.
  • 240 funds tracked by Wall St. Rank held Evolent Health as of Q3 2025.

Based on Principal Financial Group's 13F filing for Q3 2025, filed 4 Nov 2025.